TheraPten Biosciences' Unattributed - II Round

TheraPten Biosciences raised a round of funding on July 16, 2018.

TheraPten is a Canadian biotech company developing PTEN-L, the world's first natural human anti-cancer tumor suppressor protein, as an injectable biological therapy.…

Articles about TheraPten Biosciences' Unattributed - II Round: